Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Rituximab 43 Cyclophosphamide 41 fludarabine phosphate 24 Filgrastim 19 fludarabine 16 Lenalidomide 15 Bendamustine Hydrochloride 15 Peripheral Blood Stem Cell Transplantation 14 Bortezomib 13 Etoposide 11 venetoclax 10 ibrutinib 10 Radiotherapy 10 Biopsy 10 aldesleukin 9 Vincristine 9 Prednisone 9 Magnetic Resonance Spectroscopy 9 Vorinostat 8 Specimen Handling 8 Cytarabine 8 Cyclosporine 8 pembrolizumab 7 obinutuzumab 7 Paclitaxel 7 Gemcitabine 7 Flow Cytometry 7 tanespimycin 6 Tacrolimus 6 Methylprednisolone 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, Follicular × lucatumumab × Clear all

NCT01275209 2020-12-08

LIFT

Novartis

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡